Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.
Clinical trial NCT07051928 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07051928
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.